STEPS
Now enrolling patients in a Phase 3 clinical trial evaluating GATTEX™ (teduglutide) for reducing parenteral nutrition (PN) dependence in short-bowl syndrome (SBS) patients.  To learn more click here.

REPLACE
Now enrolling patients in a Phase 3 clinical trial, known as REPLACE, evaluating NPSP558 (recombinant full-length human parathyroid hormone 1-84) for the treatment of hypoparathyroidism.  To learn more click here